Fever News and Research

RSS

NIH awards United Therapeutics $45 million contract to develop potential oral treatment for viruses

The National Institutes of Health (NIH) has awarded United Therapeutics Corporation a contract for up to $45 million over five years "to help develop a potential oral treatment for viruses like influenza and the mosquito-borne tropical fever dengue," the Associated Press/Washington Post reports.

12 Oct 2011

Vertex announces availability of INCIVEK to treat hepatitis C in Canada

Vertex Pharmaceuticals Incorporated announced today that INCIVEK (telaprevir) tablets are now available in Canada for people with genotype 1 chronic hepatitis C with compensated liver disease, including cirrhosis.

11 Oct 2011

Unither Virology receives NIAID contract for glycobiology antiviral platform

United Therapeutics Corporation announced that its subsidiary, Unither Virology, LLC, has been awarded a contract for up to approximately $45 million under a Broad Agency Announcement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for studies directed at the development of a broad-spectrum antiviral drug based on its glycobiology antiviral platform.

10 Oct 2011

New laboratory in Kenya will research, monitor emerging infectious diseases

"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.

7 Oct 2011

Pakistan facing dengue outbreak, humanitarian aid shortages for flood victims

"More than 12,000 have been infected and 125 people have died over the past two months in Pakistan after coming down with dengue fever, a health department spokesman said Friday," CNN reports.

4 Oct 2011

CSL pays heed to FDA observations on faulty manufacturing processes

Australia’s biggest pharmaceutical company CSL has taken steps to address most manufacturing flaws highlighted by the US Food and Drug Administration (FDA) and promised that the remaining concerns are being resolved.

2 Oct 2011

Experiments demonstrate how mosquitoes spread diseases

The carbon dioxide we exhale and the odors our skins emanate serve as crucial cues to female mosquitoes on the hunt for human hosts to bite and spread diseases such as malaria, dengue and yellow fever.

1 Oct 2011

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

David, a 67-year-old father of three and soon to be first-time grandfather, felt too young to be diagnosed with prostate cancer. "I felt great," he said. "I had no symptoms." David, under the advisement of his oncologist, decided to be treated with PROVENGE (sipuleucel-T), the first in a new therapeutic class known as autologous cellular immunotherapies.

1 Oct 2011

Dengue fever outbreak overwhelms northeastern Kenyan town; WHO sends essential drugs

"An outbreak of dengue fever in Mandera, northeastern Kenya, is spreading fast, with at least 5,000 people infected within weeks, due to limited health facilities, a shortage of medical personnel and poor sanitation, officials told IRIN."

1 Oct 2011

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Pfizer Inc. today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of invasive aspergillosis, a life-threatening invasive fungal infection that can develop as a complication in patients with compromised immune systems.

1 Oct 2011

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Vertex Pharmaceuticals Incorporated today announced that abstracts from its hepatitis C program, including two late-breaking posters from studies of INCIVEK (telaprevir) tablets and VX-222, were accepted for presentation at The Liver Meeting, the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, November 4-8, 2011.

1 Oct 2011

Baxter seeks European marketing authorization for HyQ to treat PI

Baxter International Inc. announced today that it has submitted an application to the European Medicines Agency's Committee for Human Medicinal Products seeking marketing authorization for HyQ. HyQ is Baxter's investigational immunoglobulin (IG) therapy administered subcutaneously and facilitated by recombinant human hyaluronidase, a dispersion and permeation enhancer, for use in patients with primary immunodeficiencies.

From Baxter International Inc. 1 Oct 2011

Increased focus on vaccine for dengue fever is critical to curb spread of disease

In this GlobalPost opinion piece, Zulfiqar Bhutta, Husein Laljee Dewraj professor and head of the Division of Maternal and Child Health at the Aga Khan University Medical Center in Karachi, Pakistan, and Ciro de Quadros, executive vice president of the Sabin Vaccine Institute and former director of the Division of Vaccines and Immunization at PAHO, examine the need for a dengue fever vaccine as Pakistan struggles to curb an outbreak of the disease that to date has killed 60 people and has infected more than 8,000.

30 Sep 2011

AstraZeneca settles SEROQUEL XR patent infringement litigation

AstraZeneca today announced it has entered into a settlement agreement in its U.S. SEROQUEL XR patent infringement litigation against Handa Pharmaceuticals, LLC regarding Handa's proposed generic version of AstraZeneca's SEROQUEL XR extended-release tablets.

30 Sep 2011

Contaminated Cantaloupes carrying listeria leads to one of the worst outbreaks

According to federal health officials Tuesday, at least 13 people are dead amid 72 sickened in 18 states in an outbreak of listeria food poisoning tied to contaminated cantaloupes.

28 Sep 2011

Emissions from livestock farms cause lung patients living nearby to experience more exacerbations

Emissions from livestock farms cause asthma and COPD patients living nearby to experience more exacerbations, according to research presented today at the European Respiratory Society's Annual Congress in Amsterdam.

28 Sep 2011

DMARDs appear to be more effective for children with arthritis

Medications known as disease-modifying anti-rheumatic drugs, or DMARDs, appear to be more effective than other treatments for children with arthritis, but there is not enough evidence to support one kind of DMARD over another, according to a new report from HHS' Agency for Healthcare Research and Quality.

28 Sep 2011

Methodist Hospital internist offers few simple suggestions to prevent cold and flu

The first few breezes of fall bring with them not only the promise of a welcome change in season, but also the threat of colds and flu. Dr. Joshua Septimus, an internist at The Methodist Hospital in Houston, offers a few simple suggestions to protect you and your family this cold and flu season. "The most useful tip I can pass along is to wash your hands," says Septimus. "It sounds so simple, but it is truly the most important thing you can do to protect yourself."

27 Sep 2011

Stony Brook University opens new center to treat valvular heart disease

Stony Brook University Medical Center has opened a new Valve Center that offers comprehensive treatment of valvular heart disease.

27 Sep 2011

Pakistan officials ask for international assistance as dengue fever outbreak overwhelms local resources

BBC News reports on a continuing outbreak of dengue fever in Pakistan's Punjab province, where "more than 8,000 cases of dengue fever have been reported in the province so far -- 7,000 in Lahore alone -- and the count continues to rise," according to the Punjab health department. According to the news service, "Doctors say more than 30 people have died of the fever so far" in the province, and "health officials estimate that more than 7,000 people are being tested daily for the virus -- 300 to 400 test positive each day".

27 Sep 2011

Fever News and Research

NIH awards United Therapeutics $45 million contract to develop potential oral treatment for viruses

Vertex announces availability of INCIVEK to treat hepatitis C in Canada

Unither Virology receives NIAID contract for glycobiology antiviral platform

New laboratory in Kenya will research, monitor emerging infectious diseases

Pakistan facing dengue outbreak, humanitarian aid shortages for flood victims

CSL pays heed to FDA observations on faulty manufacturing processes

Experiments demonstrate how mosquitoes spread diseases

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

Dengue fever outbreak overwhelms northeastern Kenyan town; WHO sends essential drugs

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Baxter seeks European marketing authorization for HyQ to treat PI

Increased focus on vaccine for dengue fever is critical to curb spread of disease

AstraZeneca settles SEROQUEL XR patent infringement litigation

Contaminated Cantaloupes carrying listeria leads to one of the worst outbreaks

Emissions from livestock farms cause lung patients living nearby to experience more exacerbations

DMARDs appear to be more effective for children with arthritis

Methodist Hospital internist offers few simple suggestions to prevent cold and flu

Stony Brook University opens new center to treat valvular heart disease

Pakistan officials ask for international assistance as dengue fever outbreak overwhelms local resources

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News